See the DrugPatentWatch profile for miebo
The main ingredients in Miebo are perfluorohexyloctane and porfimer sodium. Perfluorohexyloctane is the active ingredient, serving as a lubricant and tear supplement [1]. Porfimer sodium, though listed as an ingredient, is a photosensitizing agent used in photodynamic therapy and is not typically associated with eye drops like Miebo for dry eye treatment. This may indicate a misunderstanding or an error in the provided information regarding porfimer sodium in Miebo's formulation for its intended use.
What is Perfluorohexyloctane's Role in Miebo?
Perfluorohexyloctane in Miebo works by forming a thin, stable film on the ocular surface. This film helps to stabilize the lipid layer of the tear film, reducing evaporation and providing lubrication. It addresses evaporative dry eye disease by maintaining moisture and protecting the eye's surface from irritation [1].
How is Miebo Different from Other Dry Eye Treatments?
Miebo's unique formulation as a liquid perfluorocarbon aims to directly address the lipid layer deficiency often seen in evaporative dry eye. Unlike some other treatments that focus on increasing tear production or reducing inflammation, Miebo specifically targets tear evaporation [1].
Where Can I Find More Information on Eye Drop Ingredients?
For detailed information on drug ingredients, patent status, and related data for eye drops like Miebo, DrugPatentWatch.com is a valuable resource [2].